Low expression levels of ERCC3 and XPA in lymphoblastoid cells and low levels of XPB in lymphocytes are commonly observed in HNSCC patients and have been associated with an increased risk of developing the disease [176]. The gene discussed is ERCC3; the disease is head and neck squamous cell carcinoma.